Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 10/20 | 0.75 |
| ▸ | F2 | P00734 | 4/20 | 0.47 |
| ▸ | TMPRSS15 | P98073 | 3/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.41 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6874356 | 0.89 | F10 (0.78) | F10F2TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6870518 | 0.89 | F10 (0.94) | F10F2TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6870923 | 0.87 | F10 (0.90) | F10TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6870032 | 0.86 | F10 (0.77) | F10F2TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6873650 | 0.84 | F10 (0.72) | F10F2TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6871129 | 0.83 | F10 (0.70) | F10F2TMPRSS15CHRM4ITGB3 | |
| Trifluoroacetic Acid SCHEMBL6872129 | 0.82 | F10 (0.69) | F10F2TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6870919 | 0.82 | F10 (0.71) | F10F2TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6873052 | 0.82 | F10 (0.80) | F10TMPRSS15ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL6864661 | 0.81 | F10 (0.79) | F10TMPRSS15ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6812231-B2 | INHIBITING ACTIVATED BLOOD-COAGULATION FACTOR X | AJINOMOTO CO., INC. (JP) | 2004-11-02 | — | — | US | disclosed |
| US-20020107290-A1 | Benzamidine derivative | AJINOMOTO CO., INC. (JP) | 2002-08-08 | — | — | US | disclosed |
| US-6410538-B2 | ANTICOAGULANT OR AN AGENT FOR TREATING OR PREVENTING THROMBI OR EMBOLI | AJINOMOTO CO., INC. (JP) | 2002-06-25 | — | — | US | disclosed |
| US-20010056123-A1 | Anticoagulant or an agent for treating or preventing thrombi or emboli | AJINOMOTO CO., INC (JP) | 2001-12-27 | — | — | US | disclosed |
| EP-1086946-A1 | BENZAMIDINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2001-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107290-A1 | Benzamidine derivative | SERPINE1, SERPINC1, TFPI | F10 21/4885F2 6/4885TMPRSS15 276/4885 |
| US-20010056123-A1 | Anticoagulant or an agent for treating or preventing thrombi or emboli | SERPINC1, SERPINE1, F2 | F10 16/4885F2 3/4885TMPRSS15 116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.